Reference health
Development of dissolving microneedles for intradermal delivery of the long-acting antiretroviral drug bictegravir
55/55 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 55 checked references that resolve
resolves10.3390/pharmaceutics11070308
Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin
resolves10.1016/j.addr.2006.09.017
Freeze-drying of nanoparticles: Formulation, process and storage considerations☆
resolves10.3390/pharmaceutics10030086
Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation–Processing Aspects and Challenges
resolves10.3390/pharmaceutics12100954
Effective Dispensing Methods for Loading Drugs Only to the Tip of DNA Microneedles
resolves10.1002/admt.201900552
Advances in the Formulations of Microneedles for Manifold Biomedical Applications
resolves10.1007/s11095-020-02887-9
Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems
resolves10.3390/pharmaceutics13081112
Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters
resolves10.1016/j.ijpharm.2019.04.075
Dissolving microneedle based transdermal delivery of therapeutic peptide analogues
resolves10.1016/j.drudis.2017.10.013
Microarray patches: potentially useful delivery systems for long-acting nanosuspensions
resolves10.1016/j.ijpharm.2013.04.045
Hydrogel-forming microneedle arrays exhibit antimicrobial properties: Potential for enhanced patient safety
resolves10.1016/j.ejps.2015.02.018
In vitro skin models as a tool in optimization of drug formulation
resolves10.1016/j.ijpharm.2011.01.002
Electrically enhanced solute permeation across poly(ethylene glycol)–crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: Effect of hydrogel crosslink density and ionic conductivity
resolves10.1016/j.ejpb.2014.12.020
Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: A review
resolves10.1097/COH.0000000000000158
Implementation challenges for long-acting antivirals as treatment
resolves10.3390/pharmaceutics13040579
Design and Evaluation of Dissolving Microneedles for Enhanced Dermal Delivery of Propranolol Hydrochloride
resolves10.1016/j.eurpolymj.2023.111836
Multifunctional low temperature-cured PVA/PVP/citric acid-based hydrogel forming microarray patches: Physicochemical characteristics and hydrophilic drug interaction
resolves10.1016/j.ijpharm.2020.119673
Current trends in polymer microneedle for transdermal drug delivery
resolves10.1007/s11095-020-02815-x
Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions
resolves10.1016/j.ajps.2014.05.005
Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability
resolves10.2174/1874613601610010034
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities
resolves10.1016/j.ijpharm.2014.05.042
A proposed model membrane and test method for microneedle insertion studies
resolves10.1126/sciadv.aaw8145
Long-acting reversible contraception by effervescent microneedle patch
resolves10.1016/j.drudis.2018.01.016
Pharmaceutical nanocrystals: production by wet milling and applications
resolves10.1039/C9TB00912D
Transdermal delivery of rapamycin with poor water-solubility by dissolving polymeric microneedles for anti-angiogenesis
resolves10.1016/S0140-6736(17)31917-7
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
resolves10.1016/j.jconrel.2018.11.002
Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension
resolves10.1016/j.addr.2021.06.002
The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis
resolves10.1016/j.jconrel.2022.03.012
Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes
resolves10.1016/j.jconrel.2023.03.003
Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug
resolves10.1007/s13346-021-01107-0
Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery
resolves10.1016/j.ejpb.2018.05.017
Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin
resolves10.1016/S2214-109X(20)30351-X
Travel time to health-care facilities, mode of transportation, and HIV elimination in Malawi: a geospatial modelling analysis
resolves10.1016/j.ijpharm.2021.120885
Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride
resolves10.1016/j.matdes.2022.111416
Ring inserts as a useful strategy to prepare tip-loaded microneedles for long-acting drug delivery with application in HIV pre-exposure prophylaxis
resolves10.3390/pharmaceutics11070346
Enhanced Intradermal Delivery of Nanosuspensions of Antifilariasis Drugs Using Dissolving Microneedles: A Proof of Concept Study
resolves10.1016/j.ejpb.2020.06.025
Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis
resolves10.1016/j.ijpharm.2011.06.002
Comminution of ibuprofen to produce nano-particles for rapid dissolution
resolves10.1016/j.ejps.2021.106040
Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity
resolves10.1016/j.jpba.2022.114698
HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissues
resolves10.1016/j.ijpharm.2017.02.011
Successful application of large microneedle patches by human volunteers
resolves10.1016/j.ejpb.2021.04.024
Etravirine-loaded dissolving microneedle arrays for long-acting delivery
resolves10.1016/j.molimm.2014.10.023
The immunology of the porcine skin and its value as a model for human skin
resolves10.1016/j.jconrel.2020.05.022
Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs
resolves10.1056/NEJMoa1904398
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
resolves10.1016/j.ejps.2020.105469
Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis
resolves10.1002/adfm.202270059
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis (Adv. Funct. Mater. 9/2022)
resolves10.1093/jac/dkab324
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
resolves10.1086/651482
Prevention of HIV Infection among Injection Drug Users in Resource‐Limited Settings
resolves10.1016/j.jconrel.2022.06.028
Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis
resolves10.1002/jin2.41
Novel nanosuspension‐based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug
The 6 references without a DOI — listed, not checked
no DOI — not checkedAntiviral activity, safety, and pharmacokinetics of bictegravir as 10-day monotherapy in HIV-1–infected adults
no DOI — not checkedGlobal HIV and AIDS statistics. https://www.avert.org/global-hiv-and-aids-statistics (accessed January 6, 2022).
no DOI — not checkedS.E. Lazerwith, R. Cai, X. Chen, G. Chin, M.C. Desai, S. Eng, R. Jacques, M. Ji, G. Jones, H. Martin, C. McMahon, M. Mish, P. Morganelli, J. Mwangi, H.-J. Pyun, U. Schmitz, G. Stepan, J. Szwarcberg, J. Tang, M. Tsiang, J. Wang, K. Wang, K. White, L. Wiser, J. Zack, H. Jin, Discovery of bictegravir (GS-9883), a novel, unboosted, once-daily HIV-1 integrase strand transfer inhibitor (INSTI) with improved pharmacokinetics and in vitro resistance profile. https://www.natap.org/2016/HIV/062016_05.htm (accessed May 15, 2022).
no DOI — not checkedPharmacokinetic drug interactions of integrase strand transfer inhibitors
no DOI — not checkedDevelopment and evaluation of dissolving microarray patches for co-administered and repeated intradermal delivery of long-acting rilpivirine and cabotegravir nanosuspensions for pediatric HIV antiretroviral therapy
no DOI — not checkedThermal analysis of polymer blends and double layer by DSC
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.ijpharm.2023.123108"><img src="https://citestamp.com/citestamped/10.1016/j.ijpharm.2023.123108/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.ijpharm.2023.123108)